Income Statement
FORTE BIOSCIENCES, INC.
FBRX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - | - | 0.04 | 18.04 | - |
|
Cost of Revenue
|
- | - | - | - | - | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - | - | 0.04 | 18.04 | - |
|
Operating Expenses
|
70.66 | 36.60 | 32.49 | 13.90 | 21.49 | 46.28 | 61.55 | 63.89 | 37.67 |
|
Research & Development
|
57.65 | 20.71 | 21.86 | 5.59 | 13.85 | 10.00 | 45.30 | 51.08 | 29.11 |
|
Selling, General & Administrative
|
12.41 | 15.41 | 10.62 | 8.30 | 7.63 | 4.22 | 16.25 | 12.81 | 8.56 |
|
Other Operating Expenses
|
- | - | - | - | - | - | - | - | - |
|
Operating Income
|
-70.66 | -36.60 | -32.49 | -13.90 | -21.49 | -46.28 | -61.51 | -45.85 | -37.67 |
|
Non-Operating Income
|
2.32 | - | - | - | - | - | 2.00 | 1.40 | -1.30 |
|
Interest Income
|
- | - | - | - | - | - | 1.56 | 1.53 | 0.60 |
|
Interest Expense
|
- | - | - | - | - | - | 3.82 | 2.94 | 1.93 |
|
Other Non-Op Income / Expense
|
-0.40 | -0.19 | -0.11 | 0.02 | -0.22 | -0.21 | - | - | - |
|
Income Before Tax
|
-68.34 | -35.48 | - | - | - | - | -63.52 | -47.26 | - |
|
Income Tax Expense
|
1.04 | - | - | - | - | - | 0.00 | 1.70 | - |
|
Non-Controlling Interest
|
- | - | - | - | - | - | - | - | - |
|
Net Income
|
-69.38 | -35.48 | -31.48 | -13.88 | -21.71 | -46.49 | -63.52 | -48.96 | -38.93 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY | Dec 31, 2020 2020 FY | Dec 31, 2019 2019 FY | Dec 31, 2018 2018 FY | Dec 31, 2017 2017 FY |
|---|---|---|---|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - | - | - | - | - |
|
EBITDA
|
-70.66 | -36.60 | -32.49 | -13.90 | -21.49 | -46.28 | -61.51 | -45.85 | -37.67 |
|
Earnings Per Share (Basic)
|
-4.71 | -12.17 | -1.00 | -0.80 | - | - | - | - | - |
|
Diluted EPS
|
-4.71 | -12.17 | -1.00 | -0.80 | - | - | - | - | - |
|
Weighted Average Shares
|
- | - | - | 17.38 | - | - | - | - | - |
|
Diluted Weighted Avg Shares
|
- | - | - | 17.38 | - | - | - | - | - |
|
Comprehensive Income
|
-69.38 | -35.47 | -31.47 | - | - | - | -63.48 | -48.94 | -38.96 |